Apredica's Clients and Their Investors
Apredica served over 25 clients in 2007, including the following:
Reata Pharmaceuticals
A biopharmaceutical company focused on major unmet clinical needs in cancer, inflammation, and neurodegenerative disease.
Thanks for sending the data so quickly. You sent the data and report
about two months faster than the last vendor I used.
Colin J. Meyer, M.D., M.B.A.
Director, Product Development
Cellicon Biotechnologies
A biotechnology company that has identified novel anti-infective drug targets and compounds for enhancing
the killing power of current antimicrobial drugs.
AdipoGenix
A biopharmaceutical company that is developing small-molecule pharmaceuticals to treat obesity and its co-morbidities via
drug candidates that reduce the number and fat content of human fat cells.
MaxThera
A biopharmaceutical company focused on the discovery and development of new treatments for
bacterial infections, especially for infections caused by bacteria that have become resistant to current drugs.
Creagen Biosciences
A Collaborative Research Organization specializing in small
molecule drug discovery, including synthetic, natural product, medicinal, and combinatorial chemistry.
Mercury Therapeutics
A biopharmaceutical company focused on developing breakthrough treatments for cancer and metabolic disease. Located in Woburn, MA.
Biotherapeutix
A biopharmaceutical company focused on the discovery and development of neuropharmaceiticals. Located in Brookline, MA.
Apredica's Clients' Investors
Investors in Apredica's clients include the following:
| 
